Status:
COMPLETED
Fuchs' Torsional Phaco Study
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Fuchs' Endothelial Dystrophy
Phacoemulsification
Eligibility:
All Genders
40-95 years
Phase:
PHASE4
Brief Summary
The primary objective is to compare the effect of torsional phacoemulsification and longitudinal phacoemulsification on central and peripheral corneal thickness/volume after cataract surgery in patien...
Detailed Description
Fuchs' endothelial dystrophy is a progressive, bilateral disease of the corneal endothelium, which eventually leads to corneal decompensation. In the early stage, some patients develop visually signif...
Eligibility Criteria
Inclusion
- Patients diagnosed with Fuchs' endothelial dystrophy (all stages) and planning to undergo cataract surgery due to visually significant cataract
- Patients should be 40 years of age or older
Exclusion
- Patients with Fuchs' dystrophy with a history of previous corneal or intraocular surgery
- Patients with a planned combined surgical procedure
- Patients who have other vision-affecting disorders than Fuchs' endothelial dystrophy
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00781027
Start Date
December 1 2008
Last Update
May 20 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Maastricht
Maastricht, Netherlands, 6202 AZ